Review



primary mouse monoclonal antibodies against cd4 sp35  (Cell Marque)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Cell Marque primary mouse monoclonal antibodies against cd4 sp35
    Representative micrographs show low and high <t>CD4,</t> CD8, and Foxp3 positive tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas. Original magnification: 400×
    Primary Mouse Monoclonal Antibodies Against Cd4 Sp35, supplied by Cell Marque, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+mouse+monoclonal+antibodies+against+cd4+sp35/pmc05790553-128-24-33?v=Cell+Marque
    Average 90 stars, based on 1 article reviews
    primary mouse monoclonal antibodies against cd4 sp35 - by Bioz Stars, 2026-08
    90/100 stars

    Images

    1) Product Images from "Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy"

    Article Title: Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy

    Journal: Pancreas

    doi: 10.1097/MPA.0000000000000914

    Representative micrographs show low and high CD4, CD8, and Foxp3 positive tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas. Original magnification: 400×
    Figure Legend Snippet: Representative micrographs show low and high CD4, CD8, and Foxp3 positive tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas. Original magnification: 400×

    Techniques Used:

    Clinicopathological Correlations of CD4, CD8, and Foxp3 Positive Lymphocytes in PDAC Patients Treated With Neoadjuvant Chemotherapy and Pancreaticoduodenectomy
    Figure Legend Snippet: Clinicopathological Correlations of CD4, CD8, and Foxp3 Positive Lymphocytes in PDAC Patients Treated With Neoadjuvant Chemotherapy and Pancreaticoduodenectomy

    Techniques Used:

    Kaplan-Meier curves for disease-free survival (A) and overall survival (B) stratified by CD4+ tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas after treated with neoadjuvant chemoradiation followed by pancreaticoduodenectomy.
    Figure Legend Snippet: Kaplan-Meier curves for disease-free survival (A) and overall survival (B) stratified by CD4+ tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas after treated with neoadjuvant chemoradiation followed by pancreaticoduodenectomy.

    Techniques Used:

    Univariate Cox Regression Analysis of Disease-free and Overall Survival in Relation to Clinicopathologic Features
    Figure Legend Snippet: Univariate Cox Regression Analysis of Disease-free and Overall Survival in Relation to Clinicopathologic Features

    Techniques Used:

    Multivariate Cox Regression Analysis of Disease-Free and Overall Survival in Relation to Clinicopathologic Features
    Figure Legend Snippet: Multivariate Cox Regression Analysis of Disease-Free and Overall Survival in Relation to Clinicopathologic Features

    Techniques Used:



    Similar Products

    primary mouse monoclonal antibodies against cd4 sp35  (Cell Marque)
    90
    Cell Marque primary mouse monoclonal antibodies against cd4 sp35
    Representative micrographs show low and high <t>CD4,</t> CD8, and Foxp3 positive tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas. Original magnification: 400×
    Primary Mouse Monoclonal Antibodies Against Cd4 Sp35, supplied by Cell Marque, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+mouse+monoclonal+antibodies+against+cd4+sp35/pmc05790553-128-24-33?v=Cell+Marque
    Average 90 stars, based on 1 article reviews
    primary mouse monoclonal antibodies against cd4 sp35 - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Representative micrographs show low and high CD4, CD8, and Foxp3 positive tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas. Original magnification: 400×

    Journal: Pancreas

    Article Title: Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy

    doi: 10.1097/MPA.0000000000000914

    Figure Lengend Snippet: Representative micrographs show low and high CD4, CD8, and Foxp3 positive tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas. Original magnification: 400×

    Article Snippet: Immunohistochemical Analysis for CD4, CD8, FOXP3 Immunohistochemistry for CD4, CD8, and FOXP3 were performed on 4-μm unstained sections from the tissue microarray blocks using primary mouse monoclonal antibodies against CD4 (1:25 dilution, SP35; Cell Marque, Rocklin, Calif), CD8 (1:20 dilution from predilute, C8/144B; Thermo Scientific, Fremont, Calif), and FOXP3 (1:50 dilution, clone 206D, BioLegend, San Diego, Calif).

    Techniques:

    Clinicopathological Correlations of CD4, CD8, and Foxp3 Positive Lymphocytes in PDAC Patients Treated With Neoadjuvant Chemotherapy and Pancreaticoduodenectomy

    Journal: Pancreas

    Article Title: Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy

    doi: 10.1097/MPA.0000000000000914

    Figure Lengend Snippet: Clinicopathological Correlations of CD4, CD8, and Foxp3 Positive Lymphocytes in PDAC Patients Treated With Neoadjuvant Chemotherapy and Pancreaticoduodenectomy

    Article Snippet: Immunohistochemical Analysis for CD4, CD8, FOXP3 Immunohistochemistry for CD4, CD8, and FOXP3 were performed on 4-μm unstained sections from the tissue microarray blocks using primary mouse monoclonal antibodies against CD4 (1:25 dilution, SP35; Cell Marque, Rocklin, Calif), CD8 (1:20 dilution from predilute, C8/144B; Thermo Scientific, Fremont, Calif), and FOXP3 (1:50 dilution, clone 206D, BioLegend, San Diego, Calif).

    Techniques:

    Kaplan-Meier curves for disease-free survival (A) and overall survival (B) stratified by CD4+ tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas after treated with neoadjuvant chemoradiation followed by pancreaticoduodenectomy.

    Journal: Pancreas

    Article Title: Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy

    doi: 10.1097/MPA.0000000000000914

    Figure Lengend Snippet: Kaplan-Meier curves for disease-free survival (A) and overall survival (B) stratified by CD4+ tumor infiltrating lymphocytes in residual pancreatic ductal adenocarcinomas after treated with neoadjuvant chemoradiation followed by pancreaticoduodenectomy.

    Article Snippet: Immunohistochemical Analysis for CD4, CD8, FOXP3 Immunohistochemistry for CD4, CD8, and FOXP3 were performed on 4-μm unstained sections from the tissue microarray blocks using primary mouse monoclonal antibodies against CD4 (1:25 dilution, SP35; Cell Marque, Rocklin, Calif), CD8 (1:20 dilution from predilute, C8/144B; Thermo Scientific, Fremont, Calif), and FOXP3 (1:50 dilution, clone 206D, BioLegend, San Diego, Calif).

    Techniques:

    Univariate Cox Regression Analysis of Disease-free and Overall Survival in Relation to Clinicopathologic Features

    Journal: Pancreas

    Article Title: Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy

    doi: 10.1097/MPA.0000000000000914

    Figure Lengend Snippet: Univariate Cox Regression Analysis of Disease-free and Overall Survival in Relation to Clinicopathologic Features

    Article Snippet: Immunohistochemical Analysis for CD4, CD8, FOXP3 Immunohistochemistry for CD4, CD8, and FOXP3 were performed on 4-μm unstained sections from the tissue microarray blocks using primary mouse monoclonal antibodies against CD4 (1:25 dilution, SP35; Cell Marque, Rocklin, Calif), CD8 (1:20 dilution from predilute, C8/144B; Thermo Scientific, Fremont, Calif), and FOXP3 (1:50 dilution, clone 206D, BioLegend, San Diego, Calif).

    Techniques:

    Multivariate Cox Regression Analysis of Disease-Free and Overall Survival in Relation to Clinicopathologic Features

    Journal: Pancreas

    Article Title: Prognostic Significance of Tumor Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy

    doi: 10.1097/MPA.0000000000000914

    Figure Lengend Snippet: Multivariate Cox Regression Analysis of Disease-Free and Overall Survival in Relation to Clinicopathologic Features

    Article Snippet: Immunohistochemical Analysis for CD4, CD8, FOXP3 Immunohistochemistry for CD4, CD8, and FOXP3 were performed on 4-μm unstained sections from the tissue microarray blocks using primary mouse monoclonal antibodies against CD4 (1:25 dilution, SP35; Cell Marque, Rocklin, Calif), CD8 (1:20 dilution from predilute, C8/144B; Thermo Scientific, Fremont, Calif), and FOXP3 (1:50 dilution, clone 206D, BioLegend, San Diego, Calif).

    Techniques: